APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intramuscular Injection of Pain Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intramuscular Injection of Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchIntramuscular Injection of Pain Medication Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Intramuscular Injection of Pain Medication Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intramuscular Injection of Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intramuscular Injection of Pain Medication Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Intramuscular Injection of Pain Medication Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Intramuscular Injection of Pain Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intramuscular Injection of Pain Medication include Yangtze River Pharmaceutical Group (YRPG), Shijiazhuang Pharmaceutical Group, Sanofi, Humanwell Healthcare, Qilu Pharmaceutical, Novartis, Merck, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Intramuscular Injection of Pain Medication market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intramuscular Injection of Pain Medication and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intramuscular Injection of Pain Medication revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Intramuscular Injection of Pain Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Intramuscular Injection of Pain Medication Segment by Company

Yangtze River Pharmaceutical Group (YRPG)

Shijiazhuang Pharmaceutical Group

Sanofi

Humanwell Healthcare

Qilu Pharmaceutical

Novartis

Merck

Roche

Pfizer

China Resources Double Crane

Hengrui Medicine

Sinopharm Group

Fresenius Kabi

Northeast Pharmaceuticals

AstraZeneca

Hikma Pharmaceuticals

Grünenthal

Intramuscular Injection of Pain Medication Segment by Type

Opioid Analgesics (Opioids)

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Local Anesthetics

Others

Intramuscular Injection of Pain Medication Segment by Application

Hospital

Clinic

Others

Intramuscular Injection of Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intramuscular Injection of Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intramuscular Injection of Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intramuscular Injection of Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Intramuscular Injection of Pain Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intramuscular Injection of Pain Medication industry.

Chapter 3: Detailed analysis of Intramuscular Injection of Pain Medication companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intramuscular Injection of Pain Medicationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Opioid Analgesics (Opioids) Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Table 4. Key Players of Local Anesthetics Table 3. Key Players of Others Table 4. Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Intramuscular Injection of Pain Medication Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Intramuscular Injection of Pain Medication Market Share by Region (2021-2026) Table 11. Global Intramuscular Injection of Pain Medication Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Intramuscular Injection of Pain Medication Market Share by Region (2027-2032) Table 13. Intramuscular Injection of Pain Medication Industry Trends Table 14. Intramuscular Injection of Pain Medication Industry Drivers Table 15. Intramuscular Injection of Pain Medication Industry Opportunities and Challenges Table 16. Intramuscular Injection of Pain Medication Industry Restraints Table 17. Global Intramuscular Injection of Pain Medication Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Intramuscular Injection of Pain Medication Revenue Market Share by Company (2021-2026) Table 19. Global Intramuscular Injection of Pain Medication Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Intramuscular Injection of Pain Medication Key Company Head Office and Area Served Table 21. Global Intramuscular Injection of Pain Medication Company, Product Type & Application Table 22. Global Intramuscular Injection of Pain Medication Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Intramuscular Injection of Pain Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Intramuscular Injection of Pain Medication Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Intramuscular Injection of Pain Medication Revenue Market Share by Type (2021-2026) Table 29. Global Intramuscular Injection of Pain Medication Revenue Market Share by Type (2027-2032) Table 30. Global Intramuscular Injection of Pain Medication Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Intramuscular Injection of Pain Medication Revenue Market Share by Application (2021-2026) Table 34. Global Intramuscular Injection of Pain Medication Revenue Market Share by Application (2027-2032) Table 35. Yangtze River Pharmaceutical Group (YRPG) Company Information Table 36. Yangtze River Pharmaceutical Group (YRPG) Business Overview Table 37. Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Product Portfolio Table 39. Yangtze River Pharmaceutical Group (YRPG) Recent Development Table 40. Shijiazhuang Pharmaceutical Group Company Information Table 41. Shijiazhuang Pharmaceutical Group Business Overview Table 42. Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Product Portfolio Table 44. Shijiazhuang Pharmaceutical Group Recent Development Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sanofi Intramuscular Injection of Pain Medication Product Portfolio Table 49. Sanofi Recent Development Table 50. Humanwell Healthcare Company Information Table 51. Humanwell Healthcare Business Overview Table 52. Humanwell Healthcare Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Humanwell Healthcare Intramuscular Injection of Pain Medication Product Portfolio Table 54. Humanwell Healthcare Recent Development Table 55. Qilu Pharmaceutical Company Information Table 56. Qilu Pharmaceutical Business Overview Table 57. Qilu Pharmaceutical Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Qilu Pharmaceutical Intramuscular Injection of Pain Medication Product Portfolio Table 59. Qilu Pharmaceutical Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis Intramuscular Injection of Pain Medication Product Portfolio Table 64. Novartis Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Merck Intramuscular Injection of Pain Medication Product Portfolio Table 69. Merck Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Roche Intramuscular Injection of Pain Medication Product Portfolio Table 74. Roche Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pfizer Intramuscular Injection of Pain Medication Product Portfolio Table 79. Pfizer Recent Development Table 80. China Resources Double Crane Company Information Table 81. China Resources Double Crane Business Overview Table 82. China Resources Double Crane Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. China Resources Double Crane Intramuscular Injection of Pain Medication Product Portfolio Table 84. China Resources Double Crane Recent Development Table 85. Hengrui Medicine Company Information Table 86. Hengrui Medicine Business Overview Table 87. Hengrui Medicine Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Hengrui Medicine Intramuscular Injection of Pain Medication Product Portfolio Table 89. Hengrui Medicine Recent Development Table 90. Sinopharm Group Company Information Table 91. Sinopharm Group Business Overview Table 92. Sinopharm Group Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Sinopharm Group Intramuscular Injection of Pain Medication Product Portfolio Table 94. Sinopharm Group Recent Development Table 95. Fresenius Kabi Company Information Table 96. Fresenius Kabi Business Overview Table 97. Fresenius Kabi Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Fresenius Kabi Intramuscular Injection of Pain Medication Product Portfolio Table 99. Fresenius Kabi Recent Development Table 100. Northeast Pharmaceuticals Company Information Table 101. Northeast Pharmaceuticals Business Overview Table 102. Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio Table 104. Northeast Pharmaceuticals Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. AstraZeneca Intramuscular Injection of Pain Medication Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Hikma Pharmaceuticals Company Information Table 111. Hikma Pharmaceuticals Business Overview Table 112. Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio Table 114. Hikma Pharmaceuticals Recent Development Table 115. Grünenthal Company Information Table 116. Grünenthal Business Overview Table 117. Grünenthal Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Grünenthal Intramuscular Injection of Pain Medication Product Portfolio Table 119. Grünenthal Recent Development Table 120. North America Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 121. North America Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 122. North America Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 123. North America Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 124. North America Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) Table 126. North America Intramuscular Injection of Pain Medication Market Size by Country (2027-2032) Table 127. Europe Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 128. Europe Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 129. Europe Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 130. Europe Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 131. Europe Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) Table 133. Europe Intramuscular Injection of Pain Medication Market Size by Country (2027-2032) Table 134. China Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 135. China Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 136. China Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 137. China Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 139. Asia Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 140. Asia Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 141. Asia Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) Table 144. Asia Intramuscular Injection of Pain Medication Market Size by Country (2027-2032) Table 145. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 146. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Type (2027-2032) & (US$ Million) Table 147. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 148. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Application (2027-2032) & (US$ Million) Table 149. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) Table 151. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Intramuscular Injection of Pain Medication Product Image Figure 2. Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Intramuscular Injection of Pain Medication Market Share by Type: 2025 VS 2032 Figure 4. Opioid Analgesics (Opioids) Image Figure 5. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Image Figure 6. Local Anesthetics Image Figure 7. Others Image Figure 8. Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Intramuscular Injection of Pain Medication Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Intramuscular Injection of Pain Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 15. Global Intramuscular Injection of Pain Medication Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Intramuscular Injection of Pain Medication Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Intramuscular Injection of Pain Medication Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Intramuscular Injection of Pain Medication Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Intramuscular Injection of Pain Medication Revenue Market Share by Type (2021-2032) Figure 22. Global Intramuscular Injection of Pain Medication Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Intramuscular Injection of Pain Medication Revenue Market Share by Application (2021-2032) Figure 24. North America Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 25. North America Intramuscular Injection of Pain Medication Market Share by Type (2021-2032) Figure 26. North America Intramuscular Injection of Pain Medication Market Share by Application (2021-2032) Figure 27. North America Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 28. United States Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 29. Canada Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 31. Europe Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 32. Europe Intramuscular Injection of Pain Medication Market Share by Type (2021-2032) Figure 33. Europe Intramuscular Injection of Pain Medication Market Share by Application (2021-2032) Figure 34. Europe Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 35. Germany Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 36. France Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 38. Italy Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 39. Russia Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 41. China Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 42. China Intramuscular Injection of Pain Medication Market Share by Type (2021-2032) Figure 43. China Intramuscular Injection of Pain Medication Market Share by Application (2021-2032) Figure 44. Asia Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 45. Asia Intramuscular Injection of Pain Medication Market Share by Type (2021-2032) Figure 46. Asia Intramuscular Injection of Pain Medication Market Share by Application (2021-2032) Figure 47. Asia Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 48. Japan Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 52. India Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 53. Australia Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 58. Brazil Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 63. UAE Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 65. Chile Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Analgesics (Opioids)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Yangtze River Pharmaceutical Group (YRPG)
  • Shijiazhuang Pharmaceutical Group
  • Sanofi
  • Humanwell Healthcare
  • Qilu Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • China Resources Double Crane
  • Hengrui Medicine
  • Sinopharm Group
  • Fresenius Kabi
  • Northeast Pharmaceuticals
  • AstraZeneca
  • Hikma Pharmaceuticals
  • Grünenthal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Opioid Analgesics (Opioids)
  5. 1.2.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  6. 1.2.4 Local Anesthetics
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Intramuscular Injection of Pain Medication Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Intramuscular Injection of Pain Medication Growth Trends by Region
  15. 1.5.1 Global Intramuscular Injection of Pain Medication Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Intramuscular Injection of Pain Medication Market Size by Region (2021-2026)
  17. 1.5.3 Intramuscular Injection of Pain Medication Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Intramuscular Injection of Pain Medication Market Dynamics
  1. 2.1 Intramuscular Injection of Pain Medication Industry Trends
  2. 2.2 Intramuscular Injection of Pain Medication Industry Drivers
  3. 2.3 Intramuscular Injection of Pain Medication Industry Opportunities and Challenges
  4. 2.4 Intramuscular Injection of Pain Medication Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Intramuscular Injection of Pain Medication Revenue by Company (2021-2026)
  2. 3.2 Global Intramuscular Injection of Pain Medication Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Intramuscular Injection of Pain Medication Key Company Head office and Area Served
  4. 3.4 Global Intramuscular Injection of Pain Medication Company, Product Type & Application
  5. 3.5 Global Intramuscular Injection of Pain Medication Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Intramuscular Injection of Pain Medication Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Intramuscular Injection of Pain Medication Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Intramuscular Injection of Pain Medication Tier 1, Tier 2, and Tier 3
4 Intramuscular Injection of Pain Medication Market by Type
  1. 4.1 Global Intramuscular Injection of Pain Medication Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Intramuscular Injection of Pain Medication Market Size by Type (2021-2032)
  3. 4.3 Global Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032)
5 Intramuscular Injection of Pain Medication Market by Application
  1. 5.1 Global Intramuscular Injection of Pain Medication Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Intramuscular Injection of Pain Medication Market Size by Application (2021-2032)
  3. 5.3 Global Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Yangtze River Pharmaceutical Group (YRPG)
  2. 6.1.1 Yangtze River Pharmaceutical Group (YRPG) Company Information
  3. 6.1.2 Yangtze River Pharmaceutical Group (YRPG) Business Overview
  4. 6.1.3 Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Product Portfolio
  6. 6.1.5 Yangtze River Pharmaceutical Group (YRPG) Recent Developments
  7. 6.2 Shijiazhuang Pharmaceutical Group
  8. 6.2.1 Shijiazhuang Pharmaceutical Group Company Information
  9. 6.2.2 Shijiazhuang Pharmaceutical Group Business Overview
  10. 6.2.3 Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Product Portfolio
  12. 6.2.5 Shijiazhuang Pharmaceutical Group Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sanofi Intramuscular Injection of Pain Medication Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Humanwell Healthcare
  20. 6.4.1 Humanwell Healthcare Company Information
  21. 6.4.2 Humanwell Healthcare Business Overview
  22. 6.4.3 Humanwell Healthcare Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Humanwell Healthcare Intramuscular Injection of Pain Medication Product Portfolio
  24. 6.4.5 Humanwell Healthcare Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Intramuscular Injection of Pain Medication Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Intramuscular Injection of Pain Medication Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck Intramuscular Injection of Pain Medication Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Roche Intramuscular Injection of Pain Medication Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Intramuscular Injection of Pain Medication Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 China Resources Double Crane
  56. 6.10.1 China Resources Double Crane Company Information
  57. 6.10.2 China Resources Double Crane Business Overview
  58. 6.10.3 China Resources Double Crane Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 China Resources Double Crane Intramuscular Injection of Pain Medication Product Portfolio
  60. 6.10.5 China Resources Double Crane Recent Developments
  61. 6.11 Hengrui Medicine
  62. 6.11.1 Hengrui Medicine Company Information
  63. 6.11.2 Hengrui Medicine Business Overview
  64. 6.11.3 Hengrui Medicine Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hengrui Medicine Intramuscular Injection of Pain Medication Product Portfolio
  66. 6.11.5 Hengrui Medicine Recent Developments
  67. 6.12 Sinopharm Group
  68. 6.12.1 Sinopharm Group Company Information
  69. 6.12.2 Sinopharm Group Business Overview
  70. 6.12.3 Sinopharm Group Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sinopharm Group Intramuscular Injection of Pain Medication Product Portfolio
  72. 6.12.5 Sinopharm Group Recent Developments
  73. 6.13 Fresenius Kabi
  74. 6.13.1 Fresenius Kabi Company Information
  75. 6.13.2 Fresenius Kabi Business Overview
  76. 6.13.3 Fresenius Kabi Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Fresenius Kabi Intramuscular Injection of Pain Medication Product Portfolio
  78. 6.13.5 Fresenius Kabi Recent Developments
  79. 6.14 Northeast Pharmaceuticals
  80. 6.14.1 Northeast Pharmaceuticals Company Information
  81. 6.14.2 Northeast Pharmaceuticals Business Overview
  82. 6.14.3 Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio
  84. 6.14.5 Northeast Pharmaceuticals Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 AstraZeneca Intramuscular Injection of Pain Medication Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Grünenthal
  98. 6.17.1 Grünenthal Company Information
  99. 6.17.2 Grünenthal Business Overview
  100. 6.17.3 Grünenthal Intramuscular Injection of Pain Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Grünenthal Intramuscular Injection of Pain Medication Product Portfolio
  102. 6.17.5 Grünenthal Recent Developments
7 North America
  1. 7.1 North America Intramuscular Injection of Pain Medication Market Size (2021-2032)
  2. 7.2 North America Intramuscular Injection of Pain Medication Market Size by Type
  3. 7.2.1 North America Intramuscular Injection of Pain Medication Market Size by Type (2021-2026)
  4. 7.2.2 North America Intramuscular Injection of Pain Medication Market Size by Type (2027-2032)
  5. 7.2.3 North America Intramuscular Injection of Pain Medication Market Share by Type (2021-2032)
  6. 7.3 North America Intramuscular Injection of Pain Medication Market Size by Application
  7. 7.3.1 North America Intramuscular Injection of Pain Medication Market Size by Application (2021-2026)
  8. 7.3.2 North America Intramuscular Injection of Pain Medication Market Size by Application (2027-2032)
  9. 7.3.3 North America Intramuscular Injection of Pain Medication Market Share by Application (2021-2032)
  10. 7.4 North America Intramuscular Injection of Pain Medication Market Size by Country
  11. 7.4.1 North America Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  13. 7.4.3 North America Intramuscular Injection of Pain Medication Market Size by Country (2027-2032)
  14. 7.4.4 North America Intramuscular Injection of Pain Medication Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Intramuscular Injection of Pain Medication Market Size (2021-2032)
  2. 8.2 Europe Intramuscular Injection of Pain Medication Market Size by Type
  3. 8.2.1 Europe Intramuscular Injection of Pain Medication Market Size by Type (2021-2026)
  4. 8.2.2 Europe Intramuscular Injection of Pain Medication Market Size by Type (2027-2032)
  5. 8.2.3 Europe Intramuscular Injection of Pain Medication Market Share by Type (2021-2032)
  6. 8.3 Europe Intramuscular Injection of Pain Medication Market Size by Application
  7. 8.3.1 Europe Intramuscular Injection of Pain Medication Market Size by Application (2021-2026)
  8. 8.3.2 Europe Intramuscular Injection of Pain Medication Market Size by Application (2027-2032)
  9. 8.3.3 Europe Intramuscular Injection of Pain Medication Market Share by Application (2021-2032)
  10. 8.4 Europe Intramuscular Injection of Pain Medication Market Size by Country
  11. 8.4.1 Europe Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  13. 8.4.3 Europe Intramuscular Injection of Pain Medication Market Size by Country (2027-2032)
  14. 8.4.4 Europe Intramuscular Injection of Pain Medication Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Intramuscular Injection of Pain Medication Market Size (2021-2032)
  2. 9.2 China Intramuscular Injection of Pain Medication Market Size by Type
  3. 9.2.1 China Intramuscular Injection of Pain Medication Market Size by Type (2021-2026)
  4. 9.2.2 China Intramuscular Injection of Pain Medication Market Size by Type (2027-2032)
  5. 9.2.3 China Intramuscular Injection of Pain Medication Market Share by Type (2021-2032)
  6. 9.3 China Intramuscular Injection of Pain Medication Market Size by Application
  7. 9.3.1 China Intramuscular Injection of Pain Medication Market Size by Application (2021-2026)
  8. 9.3.2 China Intramuscular Injection of Pain Medication Market Size by Application (2027-2032)
  9. 9.3.3 China Intramuscular Injection of Pain Medication Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Intramuscular Injection of Pain Medication Market Size (2021-2032)
  2. 10.2 Asia Intramuscular Injection of Pain Medication Market Size by Type
  3. 10.2.1 Asia Intramuscular Injection of Pain Medication Market Size by Type (2021-2026)
  4. 10.2.2 Asia Intramuscular Injection of Pain Medication Market Size by Type (2027-2032)
  5. 10.2.3 Asia Intramuscular Injection of Pain Medication Market Share by Type (2021-2032)
  6. 10.3 Asia Intramuscular Injection of Pain Medication Market Size by Application
  7. 10.3.1 Asia Intramuscular Injection of Pain Medication Market Size by Application (2021-2026)
  8. 10.3.2 Asia Intramuscular Injection of Pain Medication Market Size by Application (2027-2032)
  9. 10.3.3 Asia Intramuscular Injection of Pain Medication Market Share by Application (2021-2032)
  10. 10.4 Asia Intramuscular Injection of Pain Medication Market Size by Country
  11. 10.4.1 Asia Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  13. 10.4.3 Asia Intramuscular Injection of Pain Medication Market Size by Country (2027-2032)
  14. 10.4.4 Asia Intramuscular Injection of Pain Medication Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst